Literature DB >> 21258796

Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.

Franco Cozzi1, Giancarlo Parisi, Luca Ciprian, Arianna Bullo, Silvia Cardarelli, Michela Rizzo, Paolo Sfriso, Leonardo Punzi.   

Abstract

Gastric involvement appears quite commonly in systemic sclerosis (SSc). The aim of this study was to evaluate gastric wall motility using ultrasonography, a noninvasive method able to track both filling and emptying of fundus and antrum. The study was performed in 20 SSc patients and 20 healthy control subjects. Gastric filling and emptying were evaluated by transabdominal ultrasonography, measuring changes in fundus and antral areas over a 1-h period after ingestion of a liquid bolus (500 ml of mineral water). Areas of both gastric fundus and antrum at basal evaluation were found to be smaller in SSc patients than in healthy controls. Gastric filling was significantly reduced after ingestion of liquid bolus. Gastric emptying was delayed both in fundus and antrum. No significant differences of gastric wall motility have been observed in different subsets of SSc patients. Our findings show that gastric dysmotility is frequent and severe in SSc patients, contributing to the gastrointestinal disturbances which are very common in this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258796     DOI: 10.1007/s00296-010-1779-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  47 in total

1.  Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma.

Authors:  M Bortolotti; E Turba; A Tosti; P Sarti; F Brunelli; L Del Campo; L Barbara
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

Review 2.  Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.

Authors:  A Forbes; I Marie
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

3.  Esophageal deterioration in scleroderma.

Authors:  J M Garrett; R K Winkelmann; J F Schlegel; C F Code
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

Review 4.  Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone.

Authors:  B Kahaleh; M Matucci-Cerinic
Journal:  Arthritis Rheum       Date:  1995-01

5.  Measurement of gastric emptying time by real-time ultrasonography.

Authors:  L Bolondi; M Bortolotti; V Santi; T Calletti; S Gaiani; G Labò
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

Review 6.  Gastrointestinal motility disorders in scleroderma.

Authors:  R W Sjogren
Journal:  Arthritis Rheum       Date:  1994-09

Review 7.  Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

Authors:  H Sallam; T A McNearney; J D Z Chen
Journal:  Aliment Pharmacol Ther       Date:  2006-03-15       Impact factor: 8.171

8.  Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence.

Authors:  Gregory J Heyt; Mina K Oh; Nazanin Alemzadeh; Susie Rivera; Sergio A Jimenez; Satish Rattan; Sidney Cohen; Anthony J Dimarino
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

Review 9.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  M Abu-Shakra; F Guillemin; P Lee
Journal:  Semin Arthritis Rheum       Date:  1994-08       Impact factor: 5.532

10.  Abnormal colonic motility in progressive systemic sclerosis.

Authors:  W M Battle; W J Snape; S Wright; M A Sullivan; S Cohen; A Meyers; R Tuthill
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

View more
  2 in total

1.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

Review 2.  Gastrointestinal Involvement in Systemic Sclerosis: An Update.

Authors:  John B Miller; Nisarg Gandhi; John Clarke; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2018-09       Impact factor: 3.517

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.